Telomere length is short in PCOS and oral contraceptive does not affect the telomerase activity in granulosa cells of patients with PCOS.

Abstract

Our study aimed to investigate the association of telomerase activity (TA) and telomere length (TL) in granulosa cells (GCs) with IVF outcomes of polycystic ovary syndrome (PCOS) patients, and the effects of oral contraceptive pill (OCP) pretreatment on these two parameters. One hundred sixty-three infertile women were enrolled and divided into a PCOS group (n=65) and a non-PCOS group (n=98). The PCOS group was further divided into an OCP pretreatment group (n=35) and a non-OCP pretreatment group (n=30), a TA <0.070 group (n=34) and a TA ≥0.070 group (n=31), and a TL <1 group (n=41) and a TL ≥1 group (n=24), respectively. No obvious differences were observed in TA between these groups. The TL was 0.971 in PCOS group and 1.118 in non-PCOS group (P=0.005). The patients with TL ≥1 accounted for 36.9% in PCOS group and 54.1% in non-PCOS group (P=0.032). The average duration of infertility for PCOS patients was 5years in TA <0.070 group and 4years in TA ≥0.070 group (P=0.038), and 5years in TL <1 group and 3years in TL ≥1 group (P=0.006), respectively. No obvious differences were observed in IVF outcomes between these groups. No obvious differences were observed in TA, TL, or IVF outcomes between OCP pretreatment group and non-OCP pretreatment group in PCOS patients. Shorter TL was found in PCOS patients. The TA levels did not change significantly in PCOS patients. PCOS patients with a lower TA level and shorter telomeres had an earlier onset of infertility symptoms. No predictive value was found for TA and TL in terms of embryo quality or IVF outcomes in PCOS patients, and no effect OCP pretreatment was observed on either TA and TL.